Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 17;386(7):698-700.
doi: 10.1056/NEJMc2119236. Epub 2022 Jan 12.

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons

Affiliations

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons

Annika Rössler et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Neutralization of the B.1.1.529 (Omicron) Variant as Compared with Other Variants of Concern.
Serum samples were obtained from participants who had received two doses of the mRNA-1273 vaccine (Panel A), two doses of the ChAdOx1-S vaccine (Panel B), heterologous ChAdOx1-S–BNT162b2 vaccination (Panel C), or two doses of the BNT162b2 vaccine (Panel D) or who had recovered from infection (i.e., convalescent) with the B.1.1.7 (alpha) variant (Panel E), the B.1.351 (beta) variant (Panel F), or the B.1.617.2 (delta) variant (Panel G). Samples were analyzed for 50% neutralization titers (IC50) against the alpha (blue), beta (orange), delta (purple), and omicron (red) variants. Bars indicate means, and symbols individual serum samples. Samples from the same participant are connected by lines. The dashed line in each panel indicates the limit of detection. The numbers in Panels A through G indicate the proportion of serum samples that were positive (>1:16) for the omicron variant. Serum samples from participants who had been infected and were subsequently vaccinated (convalescent–vaccinated; open bars) or who had been vaccinated and subsequently had breakthrough infection (vaccinated–convalescent; shaded bars) were analyzed for IC50 against the delta and omicron variants (Panel H). In the left part of Panel H (convalescent–vaccinated), open circles indicate participants who received a single dose of the BNT162b2 vaccine after infection, and closed circles those who received two doses of the BNT162b2 vaccine; in the right part (vaccinated–convalescent), closed circles indicate participants who had been vaccinated with two doses of the BNT162b2 vaccine before infection, stars those who had been vaccinated with two doses of the ChAdOx1-S vaccine, and squares those who had been vaccinated with two doses of the mRNA-1273 vaccine.

References

    1. World Health Organization. Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern. November 26, 2021. (https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1....).
    1. Network for Genomic Surveillance in South Africa (NGS-SA). SARS-CoV-2 sequencing update. November 26, 2021. (https://www.nicd.ac.za/wp-content/uploads/2021/11/Update-of-SA-sequencin...).
    1. Pulliamn JRC, van Schalkwyk C, Govender N, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of the omicron variant in South Africa. December 2, 2021. (https://www.medrxiv.org/content/10.1101/2021.11.11.21266068v2). preprint. - DOI - PMC - PubMed
    1. Riepler L, Rössler A, Falch A, et al. Comparison of four SARS-CoV-2 neutralization assays. Vaccines (Basel) 2020;9:13-13. - PMC - PubMed
    1. Carreño JM, Alshammary H, Tcheou J, et al. Activity of convalescent and vaccine serum against SARS-CoV-2 omicron. Nature (in press) (https://www.nature.com/articles/d41586-021-03846-z). - PubMed

Supplementary concepts